An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-01

Study Completion Date

2023-01-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a single center, minimal risk, physician initiated retrospective chart review. An analysis of treatment timelines for patients diagnosed with lung cancer within the St. Elizabeth system from January 2013 until study completion. The study investigator and designee(s) will review patient electronic medical records, extracting data related to the symptom presentation, diagnosis, and treatment of new diagnoses of lung cancer. Collected data will focus on dates of encounters, diagnostic imaging/procedures, and treatments, with data analysis evaluating time between care encounters and potential delays in care. The data will be further stratified based on system-wide changes implemented to improve efficiency, patient outcomes, and patient experience.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Review of Low-Dose CT Lung Cancer Screenings in a Community-Based Healthcare System With High Incidence

NCT03560791

Non-small Cell Lung Cancer

COMPLETED

Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes

NCT07215026

Non-small Cell Lung Cancer

ENROLLING_BY_INVITATION

Circulating Tumor Cells in Non-Small Cell Lung Carcinoma

NCT01830426

Primary Lung Cancer

COMPLETED

Early Detection of Lung Cancer

NCT03181256

Lung Cancer

ACTIVE_NOT_RECRUITING

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

NCT05679349

Lung Carcinoma Tobacco-Related Carcinoma

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient seen within the St. Elizabeth system
* \>=18 years of age
* New diagnosis of histologically or cytologically documented primary lung cancer diagnosed January 2013 or later

Exclusion Criteria

* Patients with metastatic lung disease of other primary
* Other malignancies at investigator's discretion
* Patient received treatment at a facility outside of St. Elizabeth where records are not available through EPIC
* Patient currently undergoing treatment for new diagnosis of lung cancer

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No